Skip to main content
Premium Trial:

Request an Annual Quote

MDS Sciex Reports 4-Percent Rise in Organic Q4 Revenue

NEW YORK (GenomeWeb News) — MDS today reported that first-quarter revenue for its Sciex division increased 1.5 percent, though organic receipts increased 4 percent.
 
Total revenue for the three months ended Dec. 31, 2006, increased to $62 million from $61 million.
 
Driving revenue were the small molecule and applied markets and in Europe, MDS said.
 
MDS also said end-user revenue in the company’s joint ventures increased 10 percent.
 
R&D spending remained flat at $4 million.  
 
The company did not break out earnings or a balance sheet for the unit.